Giovany Orozco-Leal (Giovany Orozco Leal)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Early Breast Cancer

Tyrosine Kinase

Radiofrequency Ablation

Top Venues

Health and quality of life outcomes

PharmacoEconomics

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Anju Devianee Keetharuth, Laura A Gray, Ellen McGrane, Hannah M Worboys, Giovany Orozco-Leal
Mapping Short Warwick and Edinburgh Mental Wellbeing Scale (SWEMWBS) to Recovering Quality of Life (ReQoL) to estimate health utilities. Health and quality of life outcomes 22 (1) (2024)
Anju Devianee Keetharuth, Laura A Gray, Ellen McGrane, Hannah M Worboys, Giovany Orozco-Leal
Mapping Short Warwick and Edinburgh Mental Wellbeing Scale (SWEMWBS) to Recovering Quality of Life (ReQoL) to estimate health utilities. Health and quality of life outcomes 22 (1) (2024)
Anju Devianee Keetharuth, Laura A Gray, Ellen McGrane, Hannah M Worboys, Giovany Orozco-Leal
Mapping Short Warwick and Edinburgh Mental Wellbeing Scale (SWEMWBS) to Recovering Quality of Life (ReQoL) to estimate health utilities. Health and quality of life outcomes 22 (1) (2024)
Anju Devianee Keetharuth, Laura A Gray, Ellen McGrane, Hannah M Worboys, Giovany Orozco-Leal
Mapping Short Warwick and Edinburgh Mental Wellbeing Scale (SWEMWBS) to Recovering Quality of Life (ReQoL) to estimate health utilities. Health and quality of life outcomes 22 (1) (2024)
Giovany Orozco-Leal, Nigel Armstrong, Ashleigh Kernohan, Charlotte Ahmadu, Diarmuid Coughlan, Kevin T McDermott, Steven Duffy, Susan O'Meara, Tomos Robinson, Luke Vale, Jos Kleijnen
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics (2023)
Giovany Orozco-Leal, Eugenie Evelynne Johnson, Sedighe Hosseinijebeli, Tomos Robinson, Tara Homer, Claire H Eastaugh, Catherine Richmond, Louise Tanner, Nick Meader, Ryan P W Kenny, Sheila A Wallace, Stephen Rice
Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Evidence Assessment Group Perspective. PharmacoEconomics (2023)
Giovany Orozco-Leal, Nigel Armstrong, Ashleigh Kernohan, Charlotte Ahmadu, Diarmuid Coughlan, Kevin T McDermott, Steven Duffy, Susan O'Meara, Tomos Robinson, Luke Vale, Jos Kleijnen
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics (2023)
Fiona R Beyer, Stephen Rice, Giovany Orozco-Leal, Madeleine Still, Hannah O'Keefe, Nicole O'Connor, Akvile Stoniute, Dawn Craig, Stephen P Pereira, Louise Carr, John S Leeds
Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review. Health technology assessment (Winchester, England) 27 (7) (2023)
Rakesh Heer, Rebecca Lewis, Anne Duncan, Steven Penegar, Thenmalar Vadiveloo, Emma Clark, Ge Yu, Paramananthan Mariappan, Joanne Cresswell, John S McGrath, James N'Dow, Ghulam Nabi, A Hugh Mostafid, John Kelly, Craig R Ramsay, Henry Lazarowicz, Angela Allan, Matthew Breckons, Karen Campbell, Louise Campbell, Andrew Feber, Alison M McDonald, John Dt Norrie, Giovany Orozco-Leal, Stephen Rice, Zafer Tandoğdu, Ernest Taylor, Laura Wilson, Luke Vale, Graeme Maclennan, Emma C Hall
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT. Health technology assessment (Winchester, England) 26 (40) (2022)